Apheresis and Photopheresis

Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, features the region’s only pediatric apheresis and photopheresis program.

Apheresis and photopheresis are used to treat leukemia and sickle cell disease. Apheresis and photopheresis also fight graft-versus-host disease after bone marrow transplants and rejection after organ transplants.

Medical apheresis is the removal of specific blood components from a donor (patient) by a special machine.

The type of apheresis depends on which component needs to be removed:

  • Red blood cell exchange is an effective therapy for sickle cell disease in which damaged red cells are removed and replaced with healthy red blood cells.
  • White cell depletion uses apheresis to remove white blood cells when levels are dangerously high.
  • Red blood cell depletion removes excess red blood cells using apheresis.
  • With photopheresis, white blood cells are treated with an ultraviolet light-activated photoactive drug before being returned to the patient’s blood. This is used to treat graft-versus-host disease, organ rejection in solid organ transplants, Crohn’s disease and ulcerative colitis.
  • Plasmapheresis replaces blood plasma with plasma from a healthy donor. It is used to treat conditions such as thrombotic thrombocytopenic purpura or organ rejection after a transplant.
Cancer – 7725

Norton Children’s Cancer Institute

Talk to a member of our care team about advanced pediatric cancer care.

Call (502) 629-7725


Request an Appointment Online

COVID-19 puts pediatric patients with bleeding disorders at higher risk

Some pediatric patients with bleeding disorders may have a higher risk of severe illness from COVID-19, especially if they have serious underlying medical conditions such as heart disease, diabetes, obesity or asthma. Although most bleeding […]

Read Full Story

Diet rich in antioxidants can help prevent infection during pediatric leukemia treatment

A healthy diet that includes foods — not dietary supplements — rich in antioxidants can help kids undergoing treatment for acute lymphoblastic leukemia (ALL) reduce the risk of infection and inflammation in the digestive tract, […]

Read Full Story

Normal bruises or leukemia bruising? How to spot the difference

Leukemia bruising occurs more easily and frequently than typical bruising, may show up in odd places, tends to take longer to clear up and can be part of a number of symptoms seen on a […]

Read Full Story

Norton Children’s Cancer Institute offers clinical trials for kids with AML

It’s the news no parent wants to hear: acute myeloid leukemia (AML). This cancer of the bone marrow — the spongy tissue inside bones where blood cells are made — is rare but dangerous, affecting […]

Read Full Story

New drug treats hemophilia A in children

Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, cares for children with hemophilia, blood cancers and many other diseases. Emicizumab is a new drug now being used for children with moderate to […]

Read Full Story
Related Stories

COVID-19 puts pediatric patients with bleeding disorders at higher risk

Some pediatric patients with bleeding disorders may have a higher risk of severe illness from COVID-19, especially if they have serious underlying medical conditions such as heart disease, diabetes, obesity or asthma. Although most bleeding […]

Read Full Story

Diet rich in antioxidants can help prevent infection during pediatric leukemia treatment

A healthy diet that includes foods — not dietary supplements — rich in antioxidants can help kids undergoing treatment for acute lymphoblastic leukemia (ALL) reduce the risk of infection and inflammation in the digestive tract, […]

Read Full Story

Normal bruises or leukemia bruising? How to spot the difference

Leukemia bruising occurs more easily and frequently than typical bruising, may show up in odd places, tends to take longer to clear up and can be part of a number of symptoms seen on a […]

Read Full Story

Norton Children’s Cancer Institute offers clinical trials for kids with AML

It’s the news no parent wants to hear: acute myeloid leukemia (AML). This cancer of the bone marrow — the spongy tissue inside bones where blood cells are made — is rare but dangerous, affecting […]

Read Full Story

New drug treats hemophilia A in children

Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, cares for children with hemophilia, blood cancers and many other diseases. Emicizumab is a new drug now being used for children with moderate to […]

Read Full Story

Search our entire site.